Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha

Publication files not online:

Author: Bart, A.C.W. de · Quax, P.H.A. · Löwik, C.W.G.M. · Verheijen, J.H.
Type:article
Date:1995
Institution: TNO Preventie en Gezondheid
Source:Journal of Bone and Mineral Research, 9, 10, 1374-1384
Identifier: 232826
Keywords: Health · collagenase · gelatinase · interleukin 1alpha · messenger rna · metalloproteinase · plasminogen · stromelysin · tissue inhibitor of metalloproteinase · urokinase · animal cell · animal tissue · article · bone matrix · bone turnover · calvaria · cattle · controlled study · extracellular matrix · human · human cell · mouse · nonhuman · osteolysis · osteosarcoma · protein degradation · Extracellular Matrix · Human · Interleukin-1 · Metalloendopeptidases · Osteoblasts · Osteosarcoma · Plasminogen Activators · Plasminogen Inactivators · Support, Non-U.S. Gov't · Tumor Cells, Cultured · Urinary Plasminogen Activator

Abstract

Plasmin-mediated extracellular proteolysis has been implicated in the degradation of bone in normal and pathological conditions. Normal and malignant osteoblasts can produce both tissue-type plasminogen activator (t- PA) and urokinase-type plasminogen activator (u-PA). We have used the osteosarcoma cell line MG63 to address the question of whether the enhanced bone turnover in osteosarcomas is mediated by t-PA or by u-PA and to study the effect of the cytokine interleukin-1α (IL-1α), known to influence bone degradation, on the plasminogen activator production and extracellular matrix degradation in malignant osteoblastic cells. Furthermore, the effect of IL- 1α on the synthesis of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) was analyzed. u-PA production by MG63 was high (approximately 180 ng/106 cells/2,4 h). Also t-PA and PAI-1 production was observed. u-PA production was rapidly increased in MG63 by IL-1α (10 ng/ml), whereas an effect on t-PA production was only found after a prolonged incubation and hardly any effect of IL-1α on PAI-1 production was observed. mRNA analysis revealed similar effects. u-PA receptor (u-PAR) mRNA was detectable in MG63 cells and could be increased by IL-1α after 24 h. In MG63, u-PA-mediated extracellular matrix degradation was detectable, and IL-1α increased the u- PA-mediated matrix degradation (approximately 2-fold). Under control conditions in MG63, only MMP-2, TIMP-1, and TIMP-2 mRNA could be observed. After the addition of IL-1α, a very rapid increase in MMP-1 and MMP-3 mRNA could be observed as well as a moderate increase in TIMP-1 mRNA. The presence of MMP-2 was demonstrated by gelatin zymography. These results show that IL- 1α can stimulate u-PA production and can regulate extracellular proteolytic activity mainly via u-PA induction in the MG63 osteosarcoma cell line. Furthermore, IL-1α has a strong stimulating effect on the production of MMP- 1 and MMP-3. These findings suggest that u-PA and possibly MMP-1 and MMP-3 play an important role in the process of bone turnover in osteosarcomas. Chemicals/CAS: collagenase, 37288-86-1, 39433-96-0, 9001-12-1; gelatinase, 9040-48-6; metalloproteinase, 81669-70-7; plasminogen, 9001-91-6; stromelysin, 79955-99-0; tissue inhibitor of metalloproteinase, 97837-28-0; urokinase, 139639-24-0; Interleukin-1; Metalloendopeptidases, EC 3.4.24; Plasminogen Activators, EC 3.4.21.-; Plasminogen Inactivators; Urinary Plasminogen Activator, EC 3.4.21.73